Nifty
Sensex
:
:
13055.15
44523.02
128.70 (1.00%)
445.87 (1.01%)

Pharmaceuticals & Drugs - Global

Rating :
65/99  (View)

BSE: 531633 | NSE: LINCOLN

239.25
8.55 (3.71%)
24-Nov-2020 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  234.35
  •  243.95
  •  232.85
  •  230.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  331814
  •  793.86
  •  283.45
  •  85.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 462.90
  • 8.26
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 453.39
  • 0.65%
  • 1.33

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.41%
  • 9.46%
  • 49.26%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 8.87%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.15
  • -0.69
  • 2.34

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.27
  • 10.09
  • 4.61

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 28.56
  • 16.78
  • 14.11

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.11
  • 10.83
  • 8.35

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.44
  • 1.78
  • 1.53

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.83
  • 7.30
  • 6.62

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
126
113
12%
104
97
7%
78
79
-1%
99
84
17%
Expenses
96
88
9%
82
78
5%
70
68
3%
85
71
20%
EBITDA
30
25
21%
22
19
16%
9
11
-23%
13
14
-3%
EBIDTM
24%
22%
21%
20%
11%
14%
13%
16%
Other Income
1
3
-76%
2
1
40%
4
-1
-
3
0
700%
Interest
0
1
-
1
1
3%
-1
1
-
1
1
90%
Depreciation
2
2
7%
2
2
2%
2
2
11%
2
2
-3%
PBT
29
25
15%
21
18
20%
12
8
46%
13
11
15%
Tax
8
6
29%
6
5
19%
3
-1
-
2
2
-6%
PAT
21
19
11%
15
13
20%
9
9
5%
11
9
19%
PATM
17%
17%
15%
13%
11%
11%
11%
11%
EPS
10.46
9.46
11%
7.63
6.34
20%
4.47
4.26
5%
5.46
4.57
19%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
407
386
366
361
360
400
266
210
195
188
177
Net Sales Growth
9%
6%
2%
0%
-10%
50%
26%
8%
4%
6%
 
Cost Of Goods Sold
195
138
136
156
203
255
161
124
114
112
106
Gross Profit
212
248
230
204
157
146
105
87
81
76
71
GP Margin
52%
64%
63%
57%
44%
36%
39%
41%
41%
40%
40%
Total Expenditure
333
321
299
308
314
360
240
190
179
174
167
Power & Fuel Cost
-
8
7
7
6
6
4
3
2
1
1
% Of Sales
-
2%
2%
2%
2%
1%
2%
2%
1%
0%
0%
Employee Cost
-
59
52
51
38
29
18
19
18
17
14
% Of Sales
-
15%
14%
14%
10%
7%
7%
9%
9%
9%
8%
Manufacturing Exp.
-
64
61
52
29
36
26
19
18
17
16
% Of Sales
-
17%
17%
14%
8%
9%
10%
9%
9%
9%
9%
General & Admin Exp.
-
21
21
18
15
20
19
15
13
13
8
% Of Sales
-
6%
6%
5%
4%
5%
7%
7%
7%
7%
4%
Selling & Distn. Exp.
-
27
20
21
20
10
9
8
13
14
22
% Of Sales
-
7%
5%
6%
6%
3%
4%
4%
7%
7%
13%
Miscellaneous Exp.
-
4
2
3
3
4
3
2
1
1
22
% Of Sales
-
1%
1%
1%
1%
1%
1%
1%
1%
1%
0%
EBITDA
74
66
67
52
47
41
26
20
15
14
10
EBITDA Margin
18%
17%
18%
15%
13%
10%
10%
10%
8%
7%
5%
Other Income
10
11
6
5
3
7
7
2
6
3
3
Interest
1
2
4
5
7
10
8
7
8
8
5
Depreciation
7
7
7
6
6
5
5
4
3
2
2
PBT
74
67
62
46
37
33
20
12
11
7
6
Tax
18
16
13
12
9
9
5
2
2
2
2
Tax Rate
25%
23%
22%
25%
25%
28%
24%
16%
16%
30%
33%
PAT
56
51
49
35
28
24
15
11
10
5
4
PAT before Minority Interest
56
51
49
35
28
24
15
10
10
5
4
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
14%
13%
13%
10%
8%
6%
6%
5%
5%
3%
2%
PAT Growth
14%
6%
41%
23%
19%
58%
41%
10%
89%
23%
 
EPS
28.02
25.72
24.36
17.31
14.06
11.84
7.51
5.33
4.83
2.56
2.09

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
313
269
224
192
141
111
99
89
81
77
Share Capital
20
20
20
20
16
16
16
16
16
16
Total Reserves
293
249
204
172
117
95
82
73
64
60
Non-Current Liabilities
43
28
25
32
34
33
26
25
22
11
Secured Loans
1
2
7
12
24
15
16
14
12
3
Unsecured Loans
0
0
0
0
0
10
3
3
2
2
Long Term Provisions
33
17
7
10
0
0
0
0
0
0
Current Liabilities
80
100
113
99
100
114
131
118
105
77
Trade Payables
51
44
43
32
30
45
67
48
42
23
Other Current Liabilities
9
11
11
13
15
12
14
16
16
12
Short Term Borrowings
4
30
49
45
53
51
48
55
47
40
Short Term Provisions
16
15
10
9
2
7
2
0
0
2
Total Liabilities
437
398
363
324
275
262
260
237
212
165
Net Block
123
121
117
103
98
66
65
65
38
28
Gross Block
147
138
128
108
121
88
82
79
49
37
Accumulated Depreciation
24
17
11
5
22
22
17
14
11
9
Non Current Assets
174
159
136
134
128
81
111
114
91
45
Capital Work in Progress
0
2
0
7
3
3
2
2
14
4
Non Current Investment
0
0
0
0
0
0
0
0
0
0
Long Term Loans & Adv.
51
36
19
24
27
12
43
46
39
13
Other Non Current Assets
0
0
0
0
0
0
0
0
0
0
Current Assets
263
239
227
190
147
181
149
123
122
120
Current Investments
34
18
11
10
0
0
0
0
0
0
Inventories
47
36
45
37
27
22
24
19
21
26
Sundry Debtors
101
122
109
91
81
119
89
75
65
40
Cash & Bank
15
8
15
12
13
12
10
15
17
13
Other Current Assets
65
1
1
1
26
29
26
14
18
41
Short Term Loans & Adv.
64
54
45
39
26
29
26
14
18
41
Net Current Assets
182
139
113
90
47
67
18
5
17
43
Total Assets
437
399
363
324
275
262
260
237
212
165

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
75
53
27
25
45
25
5
-16
12
-34
PBT
67
62
46
37
33
20
12
10
5
8
Adjustment
9
9
12
11
14
11
13
9
14
7
Changes in Working Capital
14
-1
-22
-13
5
-2
-18
-32
-6
-48
Cash after chg. in Working capital
90
70
36
35
52
28
7
-14
13
-33
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-15
-18
-9
-10
-7
-3
-3
-2
-1
-2
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-31
-18
-12
-25
-42
7
1
-16
-27
-11
Net Fixed Assets
-6
-12
-12
4
-29
-4
-1
-3
-5
-12
Net Investments
-14
-7
-3
-16
-7
-1
0
0
-11
0
Others
-11
0
3
-14
-5
12
2
-13
-11
1
Cash from Financing Activity
-38
-36
-11
0
-3
-32
-11
29
16
45
Net Cash Inflow / Outflow
7
-1
3
0
0
-1
-4
-3
1
0
Opening Cash & Equivalents
5
7
3
3
4
5
9
12
12
12
Closing Cash & Equivalent
12
5
7
3
3
4
5
9
12
12

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
157
135
112
96
82
68
61
55
50
47
ROA
12%
13%
10%
9%
9%
6%
4%
4%
3%
3%
ROE
18%
20%
17%
17%
19%
14%
11%
11%
7%
6%
ROCE
22%
22%
19%
19%
21%
16%
11%
12%
11%
11%
Fixed Asset Turnover
2.81
2.84
3.07
3.19
3.90
3.20
2.67
3.10
4.45
5.60
Receivable days
102
112
101
86
90
140
139
129
101
72
Inventory Days
38
40
42
32
22
31
37
37
45
50
Payable days
57
57
48
37
40
92
116
98
75
45
Cash Conversion Cycle
84
94
95
81
72
78
60
68
71
77
Total Debt/Equity
0.02
0.12
0.27
0.34
0.59
0.69
0.69
0.85
0.86
0.60
Interest Cover
34
17
10
7
4
3
3
2
2
2

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.